STOCKHOLM, May 1, 2014 /PRNewswire/ -- As announced in October 2013, Niklas Savander will today assume the role as Elekta’s President and CEO, succeeding Tomas Puusepp who will continue as member of the company’s Board of Directors.
Niklas Savander says: “Tomas Puusepp has done a marvelous job and managed to bring out the best in people at Elekta. At Elekta we always put our customers and their patients in focus in everything we do. I am proud to take the helm of this successful and exciting company.”
Niklas Savander will present Elekta’s results for the fourth quarter and the full fiscal year on May 28; on June 17 a Capital Markets Day will be held in Stockholm.
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com
.
SOURCE Elekta
Help employers find you! Check out all the jobs and post your resume.
